Table 3. Patients with suggested changes to stage and/or treatment strategy due to ¹⁸F-FDG-PET.

		Stage
Patient no.	Disease status (P, R)	Standard	PET	Change in stage	Change in treatment
1	P	IIIA	IIA	Downstaging	Minimisation
2	R	IAE	IVA	Upstaging	Intensification
3	P	IIIB	IIB	Downstaging	No change
4	P	IIIA	IVA	Upstaging	No change
5	R	IIAE	IIIAE	Upstaging	Intensification
6	R	IIB	IIIB	Upstaging	Intensification
7	P	IVA	IIA	Downstaging	Minimisation
8	P	IIIA	IA	Downstaging	Minimisation
9	P	IIA	IIIA	Upstaging	Intensification
10	P	IIIAE	IIAE	Downstaging	Minimisation
11	P	IIA	IIAE	No change	Intensification
12	P	IIB	IB	Downstaging	Minimisation
13	P	IIA	IIIAE	Upstaging	Intensification
14	P	IIA	IVA	Upstaging	Intensification
15	P	IA	IIA	Upstaging	No change
16	P	IIIB	IVB	Upstaging	No change
17	P	IIA	IIA	No change	Intensification
18	P	IIA	IIA	No change	Minimisation
19	P	IIA	IA	Downstaging	Minimisation
20	P	IIIB	IVB	Upstaging	No change
21	P	IIIB	IVB	Upstaging	No change
22	P	IIA	IIAE	No change	Intensification

P=primary diagnosis, R=recurrent disease.